Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2.

Source:http://linkedlifedata.com/resource/pubmed/id/3484674

Download in:

View as

General Info

PMID
3484674